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1. Introduction 
The toxins from the venoms of Elapid snakes have 
been extensively studied during the past few years and 
several of them are currently used to label pharmaco- 
logical receptors and other membrane bound proteins 
[ 1,2] . On the basis of their structure and of their phar- 
macological action, Lee [ 1,3] has distinguished in 
these venoms the cardiotoxins, which, like the y-toxin, 
the direct lytic factor or cobramine B, produce cardio- 
vascular alterations responsible for local necrotic lesions 
[4] , and the neurotoxins which block synaptic trans- 
mission. The neurotoxins themselves can be subdivided 
into two main categories : 1) the a-neurotoxin, such 
as a-bungarotoxin, naja toxin or cobrotoxin are basic 
polypeptides of 60&62 or 70-74 amino acids, which 
block synaptic transmission at the neuromuscular 
junction like curare [5] and bind with a high affinity 
to the nicotinic receptor site [2,5] and, 2) the fl-neuro- 
toxins, such as P-bungarotoxin and some phospholi- 
pases A have a presynaptic action and block the 
release of acetylcholine [ 1,6,7]. 
In this letter, we describe the purification and some 
of the structural and pharmacological properties of a 
toxin which does not fall into any of these categories. 
This toxin, that we shall refer to as ceruleotoxin, is 
present in the venom of the snake Bungarus caemleus. 
It is an acidic protein which blocks the depolarisation 
of Electrophoms electroplaque by cholinergic agonists, 
even though it does not significantly bind to the nico- 
tinic receptor site. 
2. Materials and methods 
The dried venom from Bungam caeruleus was a 
gift of Dr Paul Boquet from the Service des Venins, 
Institut Pasteur, Garches. 
The toxicity of the venom and of the protein frac- 
tions during purification was determined on adult male 
mice by intravenous injection of 0.2 ml of the tested 
solution per 20 g of body weight, and expressed as 
IDloo. 
The homogeneity of the purified ceruleotoxin was 
tested by electrophoresis in polyacrylamide ge!s either 
in the absence of detergent by the method of Davis [S] 
(concentration of acrylamide 7.5%), or in the presence 
of 1% sodium dodecylsulfate as described by Fairbanks 
et al. [9] (concentration of polyacrylamide, 5.6%). 
The apparent mol. wt of the purified ceruleotoxin 
was determined by filtration on a Bio-gel P-l 50 column 
equilibrated in 0.1 M ammonium acetate at pH 7.0, 
using globular proteins of known mol. wt as standards : 
creatine kinase from Esclzericl~ia coli K12 (8 1 000 dal- 
tons), ovalbumin (43 000 daltons) and bovine cyto- 
chrome c (12 700 daltons). The apparent mol. wt of 
the subunit(s) of ceruleotoxin was measured by electro- 
phoretic migration on polyacrylamide gels in the 
presence of 1% sodium dodecyl sulfate, using : asparto- 
kinase I - homoserine dehydrogenase I from Esclzericlzia 
coli K12 (85 000 daltons), bovine serum albumin 
(67 000 daltons), ovalbumin (43 000 daltons), homo- 
serine kinase from Eschericlzia coli K12 (30 000 daltons) 
and bovine hemoglobin (15 700 daltons) as standards. 
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The pharmacological activity of the purified ceruleo- 
toxin was measured on the isolated electroplaque from 
Electrophorus electricus by the method of Schoffeniels 
and Nachmansohn [lo] and of Higman Podleski and 
Bartels [ 111 upon bath application of cholinergic 
agonist. 
The effect of ceruleotoxin on the binding of 3H 
a-toxin from Naja nigricollis was followed by the method 
of Weber and Changeux [ 121 with receptor-rich mem- 
brane fragments (spec. act. : 910 nmol in 3Hcw-toxin 
sites per gram protein) prepared from homogenates 
of Torpedo marmorata electric organ by the method 
of Cohen, Weber and Changeux [ 131. 
a-Bungarotoxin was purified from the venom of 
Bungarus multicinctus (Miami Serpentarium, Miami, 
USA) by the method of Lee [14] and Mebs [ 151. 
All chemical reagents were of analytical grade and 
from Merck and Koch-Light. 
3. Results 
3.1. Purification of ceruleotoxin 
The procedure routinely used to purify ceruleotoxin 
is summarized in table 1. One gram of dried venom 
from Bungarus caeruleus was dissolved in 15 ml of 
0.05 M Tris-HCl, pH 8.5 and the solution centrifuged 
at low speed to eliminate insoluble material. The super- 
natant (crude extract) was then added on the top of 
a QAE Sephadex A-50 column (2 X 15 cm) equilibrated 
with 0.05 M Tris-HCl, pH 8.5. A first toxic fraction 
which included the a-neurotoxin and other basic or 
neutral proteins did not adsorb to the column, and 
was released during the wash with the equilibration 
buffer. Then, a linear salt gradient (0 to 0.4 M NaCl 
in the equilibration buffer) was applied to the column, 
and a second toxic fraction was eluted at 0.125 M 
NaCl. This last toxic fraction contained the ceruleotoxin. 
It was concentrated by lyophilisation and purified to 
homogeneity by filtration on a Bio-gel P 150 (minus 
400 mesh) column (1 .l X 80 cm) equilibrated with 
0.1 M ammonium acetate pH 7.0. 
3.2. Homogeneity and molecular weight 
Fig.1 shows that the purified ceruleotoxin runs as 
a single band during polyacrylamide gel electrophore- 
sis both in the absence and in the presence of sodium 
dodecyl sulfate. Enzymatic assays indicate however 
that the preparation contains trace amounts of acetyl- 
cholinesterase (4 nmol of acetylthiocholine X min-’ X 
mg-’ of protein) as determined by the method of 
Ellman [ 161 and of phospholipase (about 1% of the 
venom phospholipase activity was recovered in the 
ceruleotoxin fraction) as determined by the indirect 
Table 1 
Purification of ceruleotoxin from Bungurus caeruleus dried venom 
Dried venom 
- 
Crude extract 
Protein Toxicity Recovery of Specific Purification 
toxicity toxicity factor 
(mg) (LD,,,) (%I (LD,,,mg-I) 
1024 17 000 100 16.6 1 
980 16 000 97.8 16.9 1.03 
First toxic fraction 
from QAE-Sephadex 
column 
810 12 000 70.7 
Second toxic fraction 
from QAE-Sephadex 
column 45 8000 47.1 
117.8 
178 10.6 
Purified ceruleotoxin 
from Bio-gel P-150 
column 
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Fig.1. (A) Disc gel electrophoresis of purified ceruleotoxin 
in a 7.5% polyacrylamide gel following the technique of Davis 
[a] ; 100 pg of purified toxin were added on top of the gel and 
Bromophenol blue was used as the tracking dye. The direction 
of migration was towards the anode. The gel was stained by 
Coomassie blue. (B) Electrophoresis in a 5.6% polyacrylamide 
gel in the presence of 1% sodium dodecyl sulfate following 
the technique of Fairbanks et al. [9] 25 fig of purified toxin 
were added on the top of the gel. 
hemolytic method described by Yang, Huang and 
Tung [17]. 
Filtration of the purified ceruleotoxin on a Bio-gel 
P-l 50 column gives an apparent mol. wt for the native 
protein of 38 000 + 4000 using globular proteins of 
known mol. wt as standards. In the presence of 1% 
sodium dodecyl sulfate, the ceruleotoxin moves as a 
single band with an apparent mol. wt of 15 000 f 2000, 
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using globular proteins as standards. The native toxin is 
therefore made up of several subunits. 
3.3. Phurmacological activity of ceruleotoxin 
The LDloo of purified ceruleotoxin determined by 
intravenous injection in mice is 0.052 pug/g body weight 
The injected animals suffer from a flaccid paralysis of 
the skeletal muscles and die from a respiratory block. 
At all the concentrations tested, the ceruleotoxin kills 
the mice with a much longer delay than the a-toxins : 
depending on the dose from 3 to 48 h instead of 10 
to 30 min. 
Fig.2 further shows that exposure of the innervated 
face of E/ectroplzonls electroplaque to 2.5 X lo-’ M 
(1 pg/ml) ceruleotoxin does not alter the resting poten- 
tial of the cell, but blocks the depolarisation caused by 
bath application of 3 X lo-’ M carbamylcholine. The 
same figure illustrates that the blocking effect of ceru- 
leotoxin develops with a much slower time course than 
that of a-toxins, for instance cu-bungarotoxin [121. 
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Fig.2. Ceruleotoxin blocks irreversibly the depolarisation of 
the isolated electroplaque from Electrophorus electricus by 
3 X 10.’ M carbamylcholine applied in bath. Right: change 
of membrane potential caused by bath application of car- 
bamylcholine. Left: the variation, as a function of time, of 
the amplitude of the depolarisation caused by bath applica- 
tion of 3 X 10.’ M carbamylcholine expressed as per cent of 
the control response. 1 pg per ml of ceruleotoxin was bath 
applied on the innervated face of the electroplaque at zero 
time. (o--o) The toxin was present during all the experiment. 
(o - - o) The toxin was washed after 12 min exposure. 
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Extensive washing of the treated cell with physiologi- 
cal solution does not modify the amplitude of the 
response. Within the time scale of the experiment the 
blocking effect of ceruleotoxin appears irreversible. 
3.4. In vitro effect of ceruleotoxin 
Ceruleotoxin was tested in vitro on Torpedo mur- 
moratu receptor-rich microsacs following either the 
efflux of 22N$ or the binding of 3H o-toxin from N@a 
nigricollis. Preincubation for 5 min at room tempera- 
ture of the excitable microsacs with ceruleotoxin at 
a concentration five-fold in excess over the concentra- 
tion of receptor sites (determined as the concentration 
of 3H o-toxin binding sites) completely blocks the 
increase of 22Na+ caused by 10e4 M carbamylcholine. 
In addition, ceruleotoxin, at variance with ai-bungaro- 
toxin, shows some effects on 22Na+ efflux at rest; it 
significantly decreases the rate of 22Na+ release and 
increases the apparent volume. 
In the same experiment and with the same mem- 
brane fragments the binding of Naja nigricollis 3H 
o-toxin was also measured after preincubation with 
ceruleotoxin or a-bungarotoxin. It was found that 
preincubation with oc-bungarotoxin reduces by 95% 
the total amount of Naja nigricollis 3H o-toxin bound 
to the membrane fragments but that the same treat- 
ment with ceruleotoxin reduces the binding of the 
tritiated toxin by only 15%. Similar results were ob- 
tained when radioactive acetylcholine, instead of 3H 
a-toxin, was used as a specific ligand of the nicotinic 
receptor site. The blocking of the response by ceruleo- 
toxin therefore does not follow its occupancy of the 
cholinergic receptor site. 
In fig.3 are compared in a more quantitative manner 
the effects of ceruleotoxin and of cr-bungarotoxin on 
the binding of 3H o-toxin from Naja nigricollis to 
receptor-rich membrane fragments from Torpedo mar- 
moratu. In both cases the membrane fragments were 
preincubated with the indicated concentration of 
toxins for 90 min at room temperature, then, the 
binding of the labelled toxin was measured. A con- 
centration of a-bungarotoxin five-fold in excess over 
the concentration of nicotinic receptor sites blocks 
more than 90% of 3H o-toxin binding sites, whereas 
the same concentration of ceruleotoxin has no signifi- 
cant effect on the binding of the labelled toxin. When 
a fifty-fold excess of ceruleotoxin was used, the bind- 
ing of 3H o-toxin decreased by only 15%; a-bungaro- 
2 0 I o-7 2. lo-’ 5.10-7 
unlabelled a- bungarotoxin or ceruleotoxin (M) 
Fig.3. Absence of effect of ceruleotoxin on the binding of 
Nuja nigricollis ‘H a-toxin to receptor-rich membrane fragments 
from Torpedo marmoruta. Receptor-rich membrane fragments 
(910 nmol of 3H a-toxin binding site per gram of protein; 
1.1 X lo-* M in “Ho-toxin binding site) were incubated in 
Torpedo physiological solution for 90 min at room tempera- 
ture with the indicated concentration of toxin. Binding of 3H 
a-toxin was then measured by millipore filtration. 
(o-o) a-Bungarotoxin from Bungarus mukicincfus. 
(0-o) Ceruleotoxin. 
toxin and ceruleotoxin therefore do not compete for 
the same binding site on the membrane fragments. 
4. Discussion 
Ceruleotoxin is a potent neurotoxin present in 
the venom of Bungurus caerulus, which can be purified 
in a homogenous form, and in milligram quantity. Even 
though ceruleotoxin primarily blocks the postsynaptic 
response to acetylcholine, it differs markedly both by 
its structure and by its pharmacological action from 
the classical o-toxins present in the same venom. It is 
an acidic protein made up of several subunits of 
about 14 000 daltons. 
Ceruleotoxin is responsible for at least 35% of the 
total toxicity of the venom. However it acts more slow- 
ly than the a-toxin both on the mouse and on the iso- 
lated Electrophorus electricus electroplaque, most 
likely because of its higher mol. wt. This slow action 
of ceruleotoxin is responsible for the paradoxal 120% 
yield in toxin recovery which follows the purification 
step on the QAE-Sephadex column : the toxicity of 
ceruleotoxin being partially masked by the fast action 
of the a-toxins present in the crude venom. 
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Ceruleotoxin, at concentrations as low as 2.5 X lo-’ 
M, blocks almost completely and irreversibly the depola- 
risation of EZectroplwrus electroplaque by carbamyl- 
choline. Moreover concentration of ceruleotoxin five- 
fold in excess over the concentration of cholinergic 
receptor site completely blocks the increase of “Naf 
efflux caused by the same agonist. However the ob- 
servation that ceruleotoxin does not compete with 
Nuja k,gricoZZis o-toxin or acetylcholine for the same 
site on receptor-rich membranes indicates that this 
aci’dic toxin does not significantly bind to the choli- 
nergic receptor site. The identification of its molecular 
target in the subsynaptic membrane might bring some 
interesting information on the ion translocating device 
that acetylcholine regulates during synaptic transmis- 
sion. 
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